PharmaResearch Co.
Rejuran
salmon DNA polynucleotide (PDRN) skin-quality injectable
Rejuran is an injectable treatment made by the South Korean company PharmaResearch Co., Ltd. It is made from polynucleotides, which are fragments of DNA purified from salmon (or, in some product lines, trout) tissue, suspended in a solution and injected into the skin. It is marketed abroad, mainly in South Korea and other parts of Asia and in Europe, for improving skin quality, such as texture and elasticity, rather than for adding volume the way a traditional filler does. The injectable is not FDA approved or cleared in the United States. A separate, differently regulated line sold under a related name in the US is a topical, not injected, cosmetic skincare product; topical cosmetics do not require the same FDA pre-market approval that an injectable device does, and that topical line should not be confused with the injectable treatment.
The record
- Made from polynucleotides (PDRN), DNA fragments purified from salmon or trout tissue.
- Manufactured by PharmaResearch Co., Ltd., a South Korean company; the company changed its name from Pharma Research Products Co., Ltd. to PharmaResearch Co., Ltd. in April 2021.
- No FDA approval or clearance record for an injectable Rejuran or polynucleotide product was found in FDA's PMA or 510(k) databases as of this research.
- Sold and marketed in South Korea and other countries; not legally marketed as an injectable in the United States as of this research.
Rejuran in our treatment room
Our own videos of this, narrated and on our YouTube channel.
Where this came from
Also in injectables
Rejuran and its logo belong to PharmaResearch Co., Ltd. (South Korea). This page describes equipment and products used at UDERMA Medspa & Laser; it is general information, not medical advice, and whether this one suits you is a conversation to have at a consultation.
Want to know if this is right for you?
UDERMA Medspa & Laser · 36426 US Hwy 19 N, Palm Harbor, FL · 727-569-6616
Book a consultation